Works matching IS 00282685 AND DT 2023 AND VI 70 AND IP 6

Results: 10

Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 811, doi. 10.4149/neo_2023_230806N413

By:

Dongming LIU;
Han MU;
Changfu LIU;
Weihao ZHANG;
Yunlong CUI;
Qiang WU;
Xiaolin ZHU;
Feng FANG;
Wei ZHANG;
Wenge XING;
Qiang LI;
Tianqiang SONG;
Wei LU;
Huikai LI

Publication type:

Article

Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 804, doi. 10.4149/neo_2023_230910N480

By:

Tian WANG;
Jie WANG;
Tianci TANG;
Li WANG;
Yi LI;
Xinmao SONG

Publication type:

Article

Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 796, doi. 10.4149/neo_2023_230721N380

By:

ROSOVA, Blanka;
PROKS, Jan;
FILIPOVA, Alzbeta;
NIKOLOV, Dimitar Hadzi;
CHLOUPKOVA, Renata;
RICHTER, Igor;
SZABO, Arpad;
ROZSYPALOVA, Aneta;
MATEJ, Radoslav;
MELICHAR, Bohuslav;
BUCHLER, Tomas;
DVORAK, Josef

Publication type:

Article

Innervation density and types of nerves in prostate cancer.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 787, doi. 10.4149/neo_2023_231116N593

By:

BLASKO, Filip;
KRIVOSIKOVA, Lucia;
BABAL, Pavel;
BREZA, Jan;
TREBATICKY, Branislav;
KURUC, Roman;
MRAVEC, Boris;
JANEGA, Pavol

Publication type:

Article

CHAC1 promotes cell ferroptosis and enhances radiation sensitivity in thyroid carcinoma.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 777, doi. 10.4149/neo_2023_230103N4

By:

Xinlin YANG;
Miao ZHANG;
Wei XIA;
Zhongchao MAI;
Ying YE;
Bin ZHAO;
Yanan SONG

Publication type:

Article

CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signaling.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 761, doi. 10.4149/neo_2023_221021N1039

By:

Zhi WANG;
Tao ZHOU;
Xubo CHEN;
Xinhua ZHU;
Bing LIAO;
Jianguo LIU;
Siqi LI;
Ting TAN;
Yuehui LIU

Publication type:

Article

Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 747, doi. 10.4149/neo_2023_230125N41

By:

Jia YUAN;
Yue CHANG;
Yalan DAI;
Yutong CHEN;
Rongbin YUE;
Linjuan ZENG

Publication type:

Article

FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 733, doi. 10.4149/neo_2023_230104N8

By:

Yanghui BI;
Yanfang YANG;
Yong ZHANG;
Caixia CHENG;
Peisen TANG;
Heng XIAO;
Fajia YUAN;
Weiwei WU;
Bin YANG

Publication type:

Article

The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 722, doi. 10.4149/neo_2023_230614N310

By:

Yongkun WANG;
Yingchun LI;
Cui RAN;
Wenjun LE;
Jiaxing DONG;
Xujing WANG;
Bo CHEN;
Xiaohua JIANG

Publication type:

Article

miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy.

Published in:

Neoplasma, 2023, v. 70, n. 6, p. 713, doi. 10.4149/neo_2023_230711N362

By:

Tian GAO;
Yong-Qing LIN;
Hai-Yan YE;
Wu-Mei LIN

Publication type:

Article